Conditional market access schemes can accelerate access to effective new treatments. To better balance their costs and health benefits, collaborative negotiation is key in pricing.
How can we design organisations in which employee well-being forms the basis for – rather than a trade-off against – performance?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback